Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2002 1
2003 2
2004 2
2005 1
2006 16
2007 25
2008 24
2009 25
2010 21
2011 29
2012 19
2013 33
2014 14
2015 3
2016 3
2017 3
2018 2
2019 4
2020 1
2021 2
2022 2
2023 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Nilotinib.
Ostendorf BN, le Coutre P, Kim TD, Quintás-Cardama A. Ostendorf BN, et al. Among authors: quintas cardama a. Recent Results Cancer Res. 2014;201:67-80. doi: 10.1007/978-3-642-54490-3_3. Recent Results Cancer Res. 2014. PMID: 24756785 Review.
Nilotinib.
Quintás-Cardama A, Kim TD, Cataldo V, le Coutre P. Quintás-Cardama A, et al. Recent Results Cancer Res. 2010;184:103-17. doi: 10.1007/978-3-642-01222-8_8. Recent Results Cancer Res. 2010. PMID: 20072834 Review.
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms.
Quintás-Cardama A, Vaddi K, Liu P, Manshouri T, Li J, Scherle PA, Caulder E, Wen X, Li Y, Waeltz P, Rupar M, Burn T, Lo Y, Kelley J, Covington M, Shepard S, Rodgers JD, Haley P, Kantarjian H, Fridman JS, Verstovsek S. Quintás-Cardama A, et al. Blood. 2010 Apr 15;115(15):3109-17. doi: 10.1182/blood-2009-04-214957. Epub 2010 Feb 3. Blood. 2010. PMID: 20130243 Free PMC article.
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors.
Livingston JA, Blay JY, Trent J, Valverde C, Agulnik M, Gounder M, Le Cesne A, McKean M, Wagner MJ, Stacchiotti S, Agresta S, Quintás-Cardama A, Reilly SA, Healy K, Hickman D, Zhao T, Ballesteros-Perez A, Khalil A, Collins MP, Piel J, Horrigan K, Lefkovith A, Innis S, Lazar AJ, Cote GM, Wagner AJ. Livingston JA, et al. Among authors: quintas cardama a. Clin Cancer Res. 2025 Feb 17;31(4):628-638. doi: 10.1158/1078-0432.CCR-24-2583. Clin Cancer Res. 2025. PMID: 39660994 Clinical Trial.
CAR-Transduced Natural Killer Cells.
Quintás-Cardama A. Quintás-Cardama A. N Engl J Med. 2020 May 7;382(19):1866. doi: 10.1056/NEJMc2004226. N Engl J Med. 2020. PMID: 32374975 No abstract available.
Tumorigenesis promotes Mdm4-S overexpression.
Pant V, Larsson CA, Aryal N, Xiong S, You MJ, Quintas-Cardama A, Lozano G. Pant V, et al. Among authors: quintas cardama a. Oncotarget. 2017 Apr 18;8(16):25837-25847. doi: 10.18632/oncotarget.15552. Oncotarget. 2017. PMID: 28460439 Free PMC article.
GPRC5D-Targeted CAR T Cells for Myeloma.
Quintás-Cardama A. Quintás-Cardama A. N Engl J Med. 2022 Dec 15;387(24):2295-2296. doi: 10.1056/NEJMc2213985. N Engl J Med. 2022. PMID: 36516097 No abstract available.
Idecabtagene Vicleucel in Relapsed Myeloma.
Quintás-Cardama A. Quintás-Cardama A. N Engl J Med. 2021 Jun 17;384(24):2357. doi: 10.1056/NEJMc2105069. N Engl J Med. 2021. PMID: 34133870 No abstract available.
p53 pathway dysfunction in AML: beyond TP53 mutations.
Post SM, Kornblau SM, Quintás-Cardama A. Post SM, et al. Among authors: quintas cardama a. Oncotarget. 2017 Nov 27;8(65):108288-108289. doi: 10.18632/oncotarget.22713. eCollection 2017 Dec 12. Oncotarget. 2017. PMID: 29312530 Free PMC article. No abstract available.
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies.
DiNardo CD, Fathi AT, Kishtagari A, Bhalla KN, Quintás-Cardama A, Reilly SA, Almon C, Patriquin C, Nabhan S, Healy K, Hickman D, Collins MP, Khalil A, Corrigan D, Zhao T, Piel J, Lyons K, Horrigan K, Schuck V, Martin P, Elliott G, Lahr DL, Bosinger M, D'Aco K, Smolen GA, Hentemann M, Loghavi S, Agresta S, Savona MR, Stein EM. DiNardo CD, et al. Among authors: quintas cardama a. Clin Cancer Res. 2025 Jun 13;31(12):2327-2338. doi: 10.1158/1078-0432.CCR-24-3790. Clin Cancer Res. 2025. PMID: 40238563 Clinical Trial.
211 results